Risk of endometrial hyperplasia progressing to cancer
- PMID: 7726278
- DOI: 10.1016/0002-9378(95)91501-x
Risk of endometrial hyperplasia progressing to cancer
Comment on
-
Incidence of endometrial hyperplasia in postmenopausal women taking conjugated estrogens (Premarin) with medroxyprogesterone acetate or conjugated estrogens alone. The Menopause Study Group.Am J Obstet Gynecol. 1994 May;170(5 Pt 1):1213-23. doi: 10.1016/s0002-9378(94)70129-6. Am J Obstet Gynecol. 1994. PMID: 8178840 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
